JPRN-jRCTs031180044招募中2 期
The study of novel therapy for patients who have intractable diarrhea symptoms by the bile acid sequestrants - The study of novel therapy for patients who have intractable diarrhea symptoms by the bile acid sequestrants
Misawa Noboru0 个研究点目标入组 50 人开始时间: 2018年11月27日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •(1) Patients who are diagnosed IBS-D or functional diarrhea by ROME criteria and have treatment for the diarrhea within 4 weeks before entry
- •(2) Patients who have more than three defecation or more than bristol score 6 per day
- •(3) Patients who are excluded mechanical disorders by colonoscopy within five years
- •(4) Patients who are 20 years old or over and under 80
排除标准
- •(1) Patients who have severe complications
- •(2) Patients who had colestimide within 4 weeks before entry
- •(3) Patients who have history of colestimide allergies
- •(4) Patients who are biliary obstruction
- •(5) Patients who are intestinal obstruction
- •(6) Patients who have narrowing of colon lumen
- •(7) Patients who have diverticular disease of intestine
- •(8) Patients who have difficulty of swallowing
- •(9) Patients who have hemorrhoid
- •(10) Patients who have or had gastrointestinal ulcer
- •(11) Patients who have bleeding tendency
- •(12) Patients who have particular drug
- •(13) Patients who have fewer than bristol score 2
- •(14) Patients who have severe psychiatric disease
- •(15) Patients who have current evidence of abuse of drugs or alcohol
- •(16) Patients who have new therapy for diarrhea within 4 weeks before entry
- •(17) Patients who had taken new drug therapy within 4 weeks before entry
- •(18) Patients who are judged as inadequately for study entry
研究者
相似试验
尚未招募
不适用
Evaluating a new treatment regimen for patients with multidrug-resistant TB (MDR-TB)HIV/AIDSTuberculosisPACTR201409000848428university of Cape Town Lung Institute256
尚未招募
Unknown
A study on fever using therapeutics of fever by H C AlleCTRI/2024/03/063748Sarada Krishna Homoeopathic medical college
进行中（未招募）
不适用
A phase II study for the treatment of patients with splenic marginal lymphoma with the combination of Cyclophosfamide, Vincristine, Liposomal Doxorubicin, Predinisone and RituximabTreatment of patients with newly diagnosed splenic marginal non Hodgkin lymphomaMedDRA version: 9.1Level: LLTClassification code 10062113Term: Splenic marginal zone lymphomaEUCTR2005-000693-45-ITG.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI
已完成
不适用
Clinical trial aimed at new therapeutic strategy for HAM by prosultiamine treatment with oral administratioHTLV-I associated myelopathy (HAM)JPRN-UMIN000005969The Department of Molecular Microbiology and Immunology25
已完成
不适用
Clinical study on alternative treatment of patients with second stage Trypanosoma brucei gambiense sleeping sicknessTrypanosoma brucei gambiense Human African Trypanosomiasis in second stageInfections and InfestationsAfrican trypanosomiasisISRCTN36877262Institute of Tropical Medicine (Belgium)600